全文获取类型
收费全文 | 54971篇 |
免费 | 4429篇 |
国内免费 | 157篇 |
专业分类
耳鼻咽喉 | 444篇 |
儿科学 | 1586篇 |
妇产科学 | 1212篇 |
基础医学 | 7519篇 |
口腔科学 | 1537篇 |
临床医学 | 5690篇 |
内科学 | 10873篇 |
皮肤病学 | 712篇 |
神经病学 | 5799篇 |
特种医学 | 2159篇 |
外国民族医学 | 7篇 |
外科学 | 7514篇 |
综合类 | 1031篇 |
一般理论 | 76篇 |
预防医学 | 4428篇 |
眼科学 | 1754篇 |
药学 | 3951篇 |
2篇 | |
中国医学 | 83篇 |
肿瘤学 | 3180篇 |
出版年
2022年 | 271篇 |
2021年 | 681篇 |
2020年 | 442篇 |
2019年 | 718篇 |
2018年 | 895篇 |
2017年 | 719篇 |
2016年 | 759篇 |
2015年 | 867篇 |
2014年 | 1218篇 |
2013年 | 2102篇 |
2012年 | 3022篇 |
2011年 | 3290篇 |
2010年 | 1749篇 |
2009年 | 1705篇 |
2008年 | 3106篇 |
2007年 | 3448篇 |
2006年 | 3398篇 |
2005年 | 3453篇 |
2004年 | 3313篇 |
2003年 | 3211篇 |
2002年 | 3136篇 |
2001年 | 790篇 |
2000年 | 707篇 |
1999年 | 747篇 |
1998年 | 739篇 |
1997年 | 645篇 |
1996年 | 549篇 |
1995年 | 582篇 |
1994年 | 544篇 |
1993年 | 520篇 |
1992年 | 617篇 |
1991年 | 653篇 |
1990年 | 593篇 |
1989年 | 491篇 |
1988年 | 546篇 |
1987年 | 482篇 |
1986年 | 513篇 |
1985年 | 526篇 |
1984年 | 611篇 |
1983年 | 512篇 |
1982年 | 538篇 |
1981年 | 527篇 |
1980年 | 519篇 |
1979年 | 434篇 |
1978年 | 409篇 |
1977年 | 411篇 |
1976年 | 315篇 |
1975年 | 325篇 |
1974年 | 330篇 |
1972年 | 251篇 |
排序方式: 共有10000条查询结果,搜索用时 265 毫秒
991.
Manoel Antonio De Paiva Neto Alexander Vandergrift Nasrin Fatemi Alessandra A. Gorgulho Antonio A. DeSalles Pejman Cohan Christina Wang Ronald Swerdloff Daniel F. Kelly 《Clinical endocrinology》2010,72(4):512-519
Objective Giant pituitary adenomas (≥40 mm) pose a major management challenge. We describe the experience of a single surgeon and a dedicated neuro‐endocrine team with multimodality treatment of these tumours in three specialized institutions. Design Retrospective data set analyses. Patients Fifty‐one consecutive patients with a giant adenoma (39 endocrine‐inactive, 12 endocrine‐active; mean tumour diameter 45 mm) treated over 10 years by an endonasal transsphenoidal approach were included. All patients had surgical resection followed by radiotherapy and/or medical therapy as judged necessary. Measurements Hormonal and visual status, extent of resection, tumour control rates, complications and use of medical and radiotherapy were evaluated. Results Surgery resulted in gross total, near total and subtotal removal in21 (41%), 10 (20%) and 20 (39%) patients respectively. Complete tumour removal was associated with absence of cavernous sinus invasion (P < 0·001). Long‐term endocrine function improved in 49% of patients and new endocrinopathy occurred in 14·6%; 76% required long‐term hormone replacement therapy. Vision improved in 81·5% of the patients and there was no visual worsening. At the last follow up (median 30 months), tumour control was achieved in 96% of patients: 59% with surgery alone, 20% with surgery plus focussed radiotherapy, 18% with surgery and medical therapy and two with all three modalities. Conclusions Endonasal surgery provides effective initial treatment for patients with giant adenomas. Multimodality therapy was needed in almost 50% of patients and this rate will likely increase with longer follow up. Close collaboration of neurosurgeons with endocrinologists and radiation oncologists is essential for optimal treatment of patients with these challenging tumours. 相似文献
992.
993.
994.
Carissa M. Baker-Smith MD Angelo S. Milazzo MD Donald P. Frush MD James Jaggers MD Margaret L. Kirby MD Ronald J. Kanter MD Piers C. Barker MD 《Congenital heart disease》2010,5(3):316-320
Aortic valve atresia with interruption of the aortic arch is an extremely rare anomaly; only eleven cases of this anomaly have been reported to date. In the absence of additional sources of blood flow to the ascending aorta, aortic valve atresia with interruption of the aortic arch is fatal. We present, to the best of our knowledge, the first case of a live birth with aortic valve atresia and interrupted left aortic arch (type B) without evidence of an aorticopulmonary communication or ductal supply to the native ascending aorta. Instead, blood flow to the native aortic root was derived from a persistent right embryonic dorsal aorta. 相似文献
995.
996.
Janice L. Y. Mong Maggie C. Y. Ng Georgia S. Guldan Claudia H. T. Tam Heung Man Lee Ronald C. W. Ma Wing Yee So Gary W. K. Wong Alice P. S. Kong Juliana C. N. Chan Mary M. Y. Waye 《Clinical endocrinology》2010,73(3):313-322
Objective: To explore the genetic effect of the GH receptor (GHR) on obesity and related metabolic parameters in Hong Kong Chinese adolescents. Context: Obesity is a growing global epidemic. Increasing evidence suggests that the GH‐IGF‐I axis plays an important role in regulating adiposity and insulin sensitivity. Design: We examined the associations of genetic variants of GHR with serum IGF‐I and IGFBP‐3 levels as well as obesity‐related metabolic traits in Hong Kong Chinese adolescents. Patients: Nine hundred and eighty‐one randomly selected Hong Kong Chinese adolescents from 14 schools. Measurements: We genotyped 17 single nucleotide polymorphisms (SNP) at GHR and measured serum IGF‐I and IGFBP‐3 levels as well as obesity‐related metabolic traits including fasting plasma glucose, insulin and lipid levels. Results: There were significant associations between rs4410646 and the body composition (P = 0·0044) and blood pressure factor scores (P = 0·00017). Carriers of the CC genotype had lower body mass index, percentage body fat, waist and hip circumferences than AC and AA genotype carriers (P = 0·00030–0·0094). There was also association between rs7703713 and the IGF‐I activity factor score (P = 0·0033). The GA and AA carriers of rs7703713 had higher serum IGF‐I, higher serum IGFBP‐3 and higher IGF‐I/IGFBP‐3 molar ratio (P = 0·00069–0·025). Haplotype analysis did not increase the significance of associations. Conclusion: Our results support the role of GHR gene polymorphisms in modulating adiposity and IGF‐I activity in adolescents. Examination of interactions of these SNPs with lifestyle, environmental and perinatal factors may provide further insights into their long‐term effects on obesity and metabolic risks. 相似文献
997.
998.
V. Valiunas G. Kanaporis L. Valiuniene C. Gordon H. Z. Wang L. Li R. B. Robinson M. R. Rosen I. S. Cohen P. R. Brink 《The Journal of physiology》2009,587(21):5211-5226
We examined whether coupling of a ventricular myocyte to a non-myocyte cell expressing HCN2 could create a two-cell syncytium capable of generating sustained pacing. Three non-myocyte cell types were transfected with the mHCN2 gene and used as sources of mHCN2-induced currents. They were human mesenchymal stem cells and HEK293 cells, both of which express connexin43 (Cx43), and HeLa cells transfected with Cx43. Cell–cell coupling between heterologous pairs increased with time in co-culture, and hyperpolarization of the myocyte induced HCN2 currents, indicating current transfer from the mHCN2-expressing cell to the myocyte via gap junctions. The magnitude of the HCN2 currents recorded in myocytes increased with increasing junctional conductance. Once a critical level of electrical cell–cell coupling between myocytes and mHCN2 transfected cells was exceeded spontaneous action potentials were generated at frequencies of ∼0.6 to 1.7 Hz (1.09 ± 0.05 Hz). Addition of carbenoxolone (200 μ m ), a gap junction channel blocker, to the media stopped spontaneous activity in heterologous cell pairs. Carbenoxolone washout restored activity. Blockade of HCN2 currents by 100 μ m 9-amino-1,2,3,4-tetrahydroacridine (THA) stopped spontaneous activity and subsequent washout restored it. Neither THA nor carbenoxolone affected electrically stimulated action potentials in isolated single myocytes. In summary, the inward current evoked in the genetically engineered (HCN2-expressing) cell was delivered to the cardiac myocyte via gap junctions and generated action potentials such that the cell pair could function as a pacemaker unit. This finding lays the groundwork for understanding cell-based biological pacemakers in vivo once an understanding of delivery and target cell geometry is defined. 相似文献
999.
1000.